Peter Richardson

Peter Richardson

Chief Tech/Sci/R&D Officer at MALLINCKRODT PLC

64 year
Health Technology
Consumer Services

Profile

Peter C.
Richardson
is currently the Chief Scientific Officer & Executive VP at Mallinckrodt Plc and a Member of The Royal College of Physicians.
Previously, he was the Chief Medical Officer & Executive VP-Research at Antares Pharma, Inc. from 2021 to 2022, the Chief Scientific Officer & Vice President at MannKind Corp.
from 2005 to 2012, the Senior VP & Global Head-Development Alliance at Novartis Pharmaceuticals Corp.
from 1991 to 2005, and the Senior Vice President & Head-Development at Novartis Pharma KK from 2003 to 2005.
He also served as the Chief Medical Officer at Adare Pharma Solutions, Inc. from 2016 to 2020.
Richardson received his undergraduate and doctorate degrees from The University of Nottingham.

Peter Richardson active positions

CompaniesPositionStart
MALLINCKRODT PLC Chief Tech/Sci/R&D Officer 2023-01-11
The Royal College of Physicians Corporate Officer/Principal -
All active positions of Peter Richardson

Former positions of Peter Richardson

CompaniesPositionEnd
ANTARES PHARMA, INC. Chief Tech/Sci/R&D Officer 2022-05-23
President 2015-12-31
MANNKIND CORPORATION Chief Tech/Sci/R&D Officer 2011-12-31
Corporate Officer/Principal 2005-09-30
Corporate Officer/Principal 2004-12-31
See the detail of Peter Richardson's experience

Training of Peter Richardson

The University of Nottingham Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Richardson's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
MANNKIND CORPORATION

Health Technology

MALLINCKRODT PLC

Health Technology

Private companies4

Health Technology

Health Technology

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Peter Richardson
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW